Desmoteplase for late treatment of stroke: still in the dark.
Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 2T9, Canada. Electronic address: michael.hill@ucalgary.ca.
Michael D
MD
Hill
Calgary Stroke Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, T2N 2T9, Canada.
Bijoy K
BK
Menon
D002545:Brain Ischemia / Q000188:drug therapy*; D002539:Cerebral Arterial Diseases / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010960:Plasminogen Activators / Q000494:pharmacology*; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*
D005343:Fibrinolytic Agents; D010960:Plasminogen Activators